
Biopharma reporter, Precision Oncology News @PrecOncNews Previously: @MMMnews @PRWeek. Views are mine, but I never tweet.
Seattle, WA
Joined March 2009
- Tweets1.4K
- Following521
- Followers484
- Likes1.6K
Alison Kanski retweeted
Replying to @MassGeneralNews
@MassGeneralNews Program to Help Doctors Balance End-of-Life Talks With Precision Oncology Optimism; story by @alisonkanski precisiononcologynews.com/ca…
Alison Kanski retweeted
Replying to @StJude
@StJude Program Installing @nanopore Sequencing in Low-Income Countries to Diagnose Pediatric Blood Cancers; great story by @alisonkanski on efforts to improve access to precision oncology outside the US...something we don't hear that much about.
precisiononcologynews.com/se…
Alison Kanski retweeted
Ten journalists have been selected for AHCJ's National Cancer Reporting Fellowship. Congratulations to @pennydickersonw, Sharon Donovan, @rosafurneaux, @CarlaKJohnson, @alisonkanski, @lalakat, @rakiyaam2, @KariOakes @journotwit, & @KDooleyYoung. ow.ly/1qNE50Hfz63
Alison Kanski retweeted
ESR1 Mutation Testing May be Informative for Personalizing SERD Treatment, #SABCS21 Studies Show; story by @alisonkanski precisiononcologynews.com/ca…
An excellent weekend 😌
Explored a completely new corner of my home state this weekend and learned that Lake Chelan is the third deepest lake in the country. Who knew?! #nwisbest
MMRF is researching a liquid biopsy test that could monitor progression of smoldering myeloma to multiple myeloma, and the data could inform precision medicine treatments for both conditions precisiononcologynews.com/ca…
Startup biotech Ariz is working to prove that the PRDM family of genes are druggable in cancer, read my piece about its research here precisiononcologynews.com/ca…
Pancreatic cancer patients harboring germline BRCA1 mutations or who have received more than six months of chemo saw the most benefit from treatment with Lynparza, the study found
precisiononcologynews.com/ca…
Alison Kanski retweeted
Replying to @pfizer
@pfizer is studying the genetic & immune features of lung cancer pts who recovered quickly & have a family history of autoimmune illness in the hopes of identifying clues to their cancer resilience precisiononcologynews.com/ca… by @alisonkanski
My first feature for Precision Oncology News! 🥳 precisiononcologynews.com/ca…
My last MM+M story posted today, a behind the scenes look at recruiting diverse and underrepresented patients for COVID-19 trials
Numerous groups are attempting to diversify COVID vaccine research. mmm-online.com/home/channel/…
Today is my first day at Precision Oncology News as their biopharma reporter! Super excited to join the team! Look out for my work here: precisiononcologynews.com/
Although pharmaceutical companies are in the spotlight due to COVID-19 and many politicians are calling for affordable prices for coronavirus drugs and vaccines, the odds of seeing moves to regulate drug prices are slim, experts say mmm-online.com/home/channel/…
Alison Kanski retweeted
SCOOP: As the presidential election fast approaches, HHS is bidding out a more than $250 million contract to a communications firm as it seeks to “defeat despair and inspire hope” about the pandemic, according to an internal HHS document I obtained. politi.co/31K6oCJ
Congrats to all the honorees!
Congrats to our fifth annual class of MM+M Hall of Femme and Women to Watch honorees! 🎉
Read through their profiles and register to join us on Sept. 22 to celebrate:
mmm-online.com/home/channel/…
Alison Kanski retweeted
Congrats to our #MMMHallofFemme cover contest winner: @PorettaOrr! 🎉
Browse all the submissions here: mmm-online.com/home/channel/…
















